Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Status

recruiting

Phase

Phase 2

Institution

Stanford University

Start date

2024-02-24

End date

2028-11-01

Registry ID

NCT05940324

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.